RESUMO
This work describes the local knowledge of the medicinal use of Stryphnodendron rotundifolium Mart., Fabaceae, according to informants in two areas of the Araripe bioregion, in the Northeast Region of Brazil. We used interviews to investigate the ethnomedicinal use of the local species to determine the mode of use, frequency of administration, duration of treatment and restrictions of use. In traditional medicine, the use of S. rotundifolium is associated with the treatment of inflammatory and infectious diseases. The part of the plant most used was the stem bark (86.11%), the predominant mode of preparation was immersion in water (52.83%), and oral administration was the most cited (48.43%). For inflammatory and infectious diseases, the treatment lasted 3-10 days and the frequency of administration was 2-3 times/day. For gastroprotective effects, treatment lasted up to 30 days, and the herb was administered 1-3 times/day. For pain complaints, the therapy varied from 2-3 days to continuous administration.The informants (46.87%) did not mention restrictions of use, except for pregnant women, with a rate of 25%. A comparison of these results with the ethnopharmacological information from other studies showed that some of the traditional indications are scientifically supported by the literature or clinical studies. Nevertheless, the results showed that pharmacologists have not fully investigated all the possible bioactivities that healers credit to this plant. .
RESUMO
Lippia gracilis Schauer (Verbenaceae) is an aromatic plant widely used in folk medicine in the Brazilian semi-arid region. This work aims at evaluating the anti-microbial activity of essential oils from the leaves of L. gracilis (EOLG) when associated with commercial antibiotics against bacterial resistance. The essential oil obtained by hydrodistillation has 38 chemical constituents with thymol (44.4%), carvacrol (22.2%), p-cymene (6.2%) and α-pinene (5.6%) as major constituents. Microbiological assays were conducted by direct and gaseous contacts. We demonstrated that EOLG has significant synergism with all antibiotics tested. EOLG decreased the minimal inhibitory concentration of the aminoglycosides and improved their zone of inhibition more than 300% against Staphylococcus aureus and 270% against Pseudomonas aeruginosa. These results demonstrate that natural substances present in EOLG have the capacity to modulate bacterial resistance and can be used as an adjuvant therapy against multi-resistant microorganisms such as S. aureus, Escherichia coli and P. aeruginosa.